Jonas Kath

6PUBLICATIONS
47CO-AUTHORS
Molecular targetsTissue engineeringApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Electrical machines and drivesReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 21, 2026
Lung tumouroids as a testing platform for precision CAR T cell therapy.

Lukas Ehlen, Martí Farrera-Sal, Martin Szyska

|Dec 09, 2025
Personalized CRISPR knock-in cytokine gene therapy to remodel the tumor microenvironment and enhance CAR T cell therapy in solid tumors.

Michael Launspach, Julia Macos, Shoaib Afzal

|Oct 13, 2025
HLA matching or CRISPR editing of HLA class I/II enables engraftment and effective function of allogeneic human regulatory T cell therapy in a humanized mouse transplantation model.

Oliver McCallion, Weijie Du, Viktor Glaser

|Mar 17, 2024
Integration of ζ-deficient CARs into the CD3ζ gene conveys potent cytotoxicity in T and NK cells.

Jonas Kath, Clemens Franke, Vanessa Drosdek

|Dec 20, 2023
Integration of ζ-deficient CARs into the CD3-zeta gene conveys potent cytotoxicity in T and NK cells.

Jonas Kath, Clemens Franke, Vanessa Drosdek

|May 17, 2023
CAR NK-92 cell-mediated depletion of residual TCR+ cells for ultrapure allogeneic TCR-deleted CAR T-cell products.

Jonas Kath, Weijie Du, Stefania Martini

Pageof 1

Frequent Collaborators

6 joint publications

Dimitrios L Wagner

4 joint publications

Annette Künkele

4 joint publications

Clemens Franke

4 joint publications

Michael Schmueck-Henneresse